ADC Therapeutics S.A.
ADCT | NYSE
$1.12
+$0.07 (+6.67%)
At close: Sep 21, 2026, 4:00 PM ET
$1.07
-$0.05 (-4.63%)
After-hours:
Sep 21, 2026, 6:09 PM ET
Market Data
Market Cap $133.55M
Enterprise Value $340.45M
Beta 1.85
Average Volume 1.78M
Shares Outstanding (Diluted) 155.02M
Shares Change YoY 36.29%
Institutional Ownership 54.18%
Exchange NYSE
ISIN CH0499880968
Price Performance
Price Change 1M 13.1%
Price Change 3M -2.6%
Price Change 6M -71.8%
Price Change YTD -68.2%
Price Change 1Y -67.8%
Price Change 3Y 55.6%
Price Change 5Y -96.0%
1M CAGR (ann.) -7.1%
1Y CAGR (ann.) -67.7%
5Y CAGR (ann.) -47.7%
All-Time CAGR -40.9%
Valuation
PE Ratio -1.70
Forward PE N/A
PEG Ratio -0.02
Forward PEG 0.15
PS Ratio 1.81
Forward PS 1.50
PB Ratio -0.62
P/FCF Ratio -1.39
P/Adj. FCF Ratio -1.21
P/OCF Ratio -1.70
EV/Sales 4.32
EV/EBIT -3.87
EV/EBITDA -3.89
EV/FCF -3.33
Earnings Yield -58.9%
FCF Yield -71.8%
Adj. FCF Yield -82.4%
Financial Health
Net Debt $198M
Total Debt $417.11M
Cash & Short-Term Investments $219.11M
Total Assets $279.38M
Current Ratio 3.03
Quick Ratio 2.97
Debt / Equity Ratio -1.83
Debt / EBITDA -4.77
Debt / FCF -4.08
OCF / Debt -0.25
Interest Coverage -1.90
Altman Z-Score -8.29
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 88.8%
Operating Profit Margin -125.8%
EBITDA Margin -111.1%
Net Profit Margin -123.0%
FCF Margin -129.9%
Adj. FCF Margin -149.1%
SBC / Revenue 19.2%
SBC Impact (per share) -14.8%
Returns
Return on Assets -34.7%
Return on Equity 44.6%
Return on Invested Capital -49.5%
Return on Capital Employed -51.3%
Return on Tangible Assets -34.7%
Historical Growth (CAGR)
Revenue CAGR 3Y -24.7%
Revenue CAGR 5Y 83.8%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 59.3%
EPS CAGR 5Y 22.4%
EPS CAGR 10Y N/A
FCF CAGR 3Y 18.1%
FCF CAGR 5Y 14.1%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 12
EPS Growth Next 3Y 38.4%
Revenue Growth Next 3Y 41.7%
Earnings Date Nov 9, 2026
EPS Estimate (next Q) -$0.21
EPS Growth Est (next Q) -30.0%
Revenue Est (next Q) $18.44M
Revenue Growth Est (next Q) 12.2%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $3.50
Price Target Upside 212.5%
Cash Flow
Operating Cash Flow $-102.27M
Free Cash Flow $-102.31M
Adj. Free Cash Flow $-117.43M
FCF Per Share -$0.66
OCF Per Share -$0.66
OCF/S Ratio -129.8%
Income Statement
Revenue $78.77M
Gross Profit $69.9M
Operating Income $-99.11M
EBITDA $-87.48M
Net Income $-96.91M
EPS (Diluted) -$0.66
Revenue / Employee $412.39K
Profit / Employee $-507.37K
Employees 191
Add to Watchlist
Select watchlists to add or remove ADCT